2,3-Dihydro-2-oxo-1H-benzimidazole-5-sulfonyl chloride hydrochloride, 95.0%, 1g

3-(Furan-2-yl)-2,4-dioxaspiro[5.5]undec-8-ene, 98%, 5mg

4-(Hydroxymethyl)bicyclo[2.2.1]heptane-1-carboxylic acid, 98%, 100mg

1-(2-Chloroethyl)pyrrolidine hydrochloride, 98.0%, 25g

TERT-BUTYL 5-METHYL-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-INDOLE-1-CARBOXYLATE, 95%, 250mg

1-(3-Chlorophenyl)piperidin-2-one, 98%, 250mg

Boîtes de Pétri avec oreilles d'aération, 35 x 10 mm, Stériles 740 pcs

Solution d'hydroxyde de sodium, min 32 %, ultra pure, 30 l, emballage plastique.

Methyl 4-(chloroformyl)butyrate, 97.0%, 25g

(9H-FLUOREN-9-YL)METHYL 2-OXOPYRROLIDINE-1-CARBOXYLATE, 95.0%, 100mg

2,5-Bis(2-octyldodecyl)-3,6-bis[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl]pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione>98.0%(HPLC)200mg

Boc-L-citrulline 4-nitrophenyl ester, 98.0%, 250mg

N-(2-aminoethyl)-N-methylmethanesulfonamide hydrochloride, 95.0%, 5g